Docket Management
Docket: 02N-0209 - Request for Comment on First Amendment Issues
Comment Number: EC -49

Accepted - Volume 1

Comment Record
Commentor Mrs. Myrna Overstreet Date/Time 2002-05-29 09:10:53
Organization Mrs. Myrna Overstreet
Category Individual

Comments for FDA General
Questions
1. Are there arguments for regulating speech about drugs more comprehensively than, for example, about dietary supplements? What must an administrative record contain to sustain such a position? In particular, could FDA sustain a position that certain promotional speech about drugs is inherently misleading, unless it complies with FDA requirements? Does anything turn on whether the speech is made to learned intermediaries or to consumers? What is the evidentiary basis of such a distinction? I believe that the consumer AND THE DOCTOR need to take more responsibility for learning all they can about drugs and supplements. The information should not be limited.




EC -49